A research facility at Karachi University (KU) in collaboration with the Indus Hospital (IH) has recently begun clinical trials of a traditional Chinese medicine to treat mild cases of Covid-19, sources told Dawn.
According to researchers at Dr Panjwani Centre for Molecular Medicine and Drug Research at KU, the trial will test the efficacy and safe use of Jinhua Qinggan Granule – a combination of natural herbs widely used during the Covid-19 outbreak in China.
It consists of 12 herbal components including honeysuckle, mint and licorice.
“The medicine tested in China has been found to have curative as well as preventive effects. It’s one of the top drugs recommended in China’s national guidelines against Covid-19,” said lead investigator of the study Prof Raza Shah, adding that the medicine had so far been given to 15 Covid-19 patients in Karachi.
Read full story here.
